ArticleChina CDC weekly2025
Serological Survey of Lymphocytic Choriomeningitis Virus (LCMV) Infection - Gansu Province, China, 2023.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Lymphocytic choriomeningitis virus (LCMV) is transmitted primarily through rodent excreta, with humans being universally susceptible to infection. Transmission via organ transplantation occurs rarely. The predominantly nonspecific clinical presentation in humans has contributed to LCMV remaining an underrecognized zoonotic pathogen. What is added by this report?: This study provides the first serological confirmation of past LCMV infection among the general population in Gansu Province, with seroprevalence rates of 18.31% by enzyme-linked immunosorbent assay (ELISA) and 1.97% by immunofluorescence analysis (IFA). Priority populations for targeted LCMV prevention and control interventions include rural residents, individuals with lower educational attainment, and agricultural workers. What are the implications for public health practice?: LCMV clinical manifestations overlap with those of pathogens targeted by national sentinel surveillance systems; LCMV should be incorporated into future screening protocols for unidentified infectious agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.